Global High-Priority Regulatory Events — May 20, 2026

Global High Priority Market Events

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

This intelligence stream reveals a bifurcated market landscape on May 20, 2026, characterized by severe distress in small-cap and micro-cap companies, counterbalanced by robust growth and strategic positioning in larger, more established firms.

The most critical developments include a delisting and Chapter 11 bankruptcy filing by Society Pass Inc., alongside a wave of negative earnings surprises and widening losses across a cohort of micro-cap entities (Powerdyne, Renewal Fuels, AppYea, Starfighters Space). Conversely, Analog Devices reported a standout 37% YoY revenue surge, while Apollo Hospitals delivered 18% top-line growth and a 31% EBITDA increase, signaling strong sector-specific demand. A significant trend is the aggressive capital market activity, with multiple SPAC IPOs (FutureCorp Space, Deep Fission) and crypto-asset trust filings (Morgan Stanley for Solana and Ethereum) indicating sustained institutional appetite for thematic and speculative assets. Period-over-period data shows a clear pattern of revenue growth failing to translate to profitability for many growth-stage companies, with operating expenses and non-cash charges eroding bottom lines. Insider activity was notably absent, but capital allocation decisions—such as debt refinancing by Avista Corp. and a $3.75B credit facility for Williams Companies—point to a focus on liquidity management. The overall sentiment is mixed, with high materiality events concentrated in bankruptcy, regulatory actions, and transformative M&A, demanding immediate attention from event-driven investors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q · S-1 · 8-K · 10-K · 425

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from May 19, 2026.

Investment Signals (12)

  • Analog Devices (ADI) (BULLISH)

    Revenue surged 37% YoY to $3.62B, with net income more than doubling to $1.18B. Industrial segment grew 56% and Communications 79%, signaling broad-based demand recovery.

  • Consolidated revenue up 18% YoY to ₹66,055 Mio, with EBITDA margin expanding to 15.3% (up 31% YoY). Healthcare Services PAT grew 36%, driven by 7% increase in in-patients and 9% higher ARPIP.

  • Net loss improved 69% to $282K from $917K, driven by a 27.5% reduction in cost of revenue and 30.9% lower payroll expenses, indicating successful cost restructuring despite a 12.2% revenue decline.

  • Service revenue surged 207.6% YoY to $3.7M, driving total revenue up 70.5% to $5.1M. Gross profit more than doubled (+102.7%), showing strong unit economics in core business.

  • Q1 2026 revenue hit a record $19.5M, up 39% YoY, with AUM reaching $3.4B and aggregated transaction volume of $1.9B. Pending business combination with Cantor Equity Partners II (CEPT) expected H1 2026.

  • Net loss of $6.1M in Q1 2026, a sharp reversal from $0.9M profit a year ago, driven by a 5x increase in provision for credit losses to $5.4M and $1.6M in transaction expenses.

  • Net loss widened 61% to $4.27M as operating expenses surged 116% to $4.05M. Cash burn is severe, with cash declining 54% to $2.14M, and a $395K loss from asset misappropriation raises governance concerns.

  • Net income plunged 52.5% YoY to $4.3M as natural gas revenue turned negative (-$1.02M vs +$6.03M). Operating cash flow dropped 57.9%, signaling deteriorating operational health.

  • Q1 2026 adjusted net income dropped sharply to $1.0M from $28.2M in FY2025, and adjusted EPS fell to $0.91, a dramatic decline post-merger integration.

  • Swung to a net loss of ₹408 Lakh in Q4 FY26 from a profit of ₹427 Lakh in Q4 FY25, with full-year net profit collapsing 77% to ₹429 Lakh. Revenue declined 17.8% YoY in Q4.

  • Announced a buyback of up to 5,48,780 shares at ₹328/share (₹18 Cr), representing 8.53% of paid-up capital. This signals management's confidence in intrinsic value and capital return policy.

  • Net income fell 42% to $97.3M despite a 2% revenue decline, as operating expenses surged 19.7% driven by an $86.5M impairment. However, gross margin expanded 400 bps to 59%, showing underlying product mix improvement.

Risk Flags (10)

  • Society Pass Inc. (SOPA) / Delisting & Bankruptcy [HIGH RISK]

    Received Nasdaq delisting notice following Chapter 11 filing on May 12, 2026. Trading will be suspended May 21, 2026. Appeal is uncertain.

  • Revenue declined 36.9% YoY, net loss more than doubled, cash fell 49% to $24K, and stockholders' deficit widened to ($507K). Trade receivables collapsed 94.3%, indicating potential business cessation.

  • Net loss surged to $669K from $100K, operating expenses spiked 532%. Stockholders' deficit is $1.1M with total liabilities of $1.2M exceeding total assets of $99K. Going concern risk is extreme.

  • Net loss increased 844% to $1.568M with zero revenue. Accumulated deficit reached $27M. Relies entirely on stock issuances for cash ($0.7M in Q1).

  • Net loss widened 47% to $66.8K with zero revenue. Total liabilities of $927K dwarf total assets of $34K. Relies on debt and related-party advances.

  • Provision for credit losses surged 391% to $5.4M, driving a net loss. Interest income from LLC investments fell 55.8%, signaling portfolio stress.

  • $395K loss from misappropriation of assets, professional fees surged 592% to $1.33M, and stock-based compensation jumped to $1.8M (from $0). Cash burn rate is unsustainable.

  • CIRP since Feb 2022. Resolution plan approval delayed again (next hearing June 2, 2026). Procedural delays increase uncertainty for creditors and equity holders.

  • Standalone Q4 FY26 swung to a loss of ₹1,063.91 lakh from a profit of ₹66.23 lakh, despite a strong full-year profit. This indicates severe seasonal or one-time operational issues.

  • Standalone Q4 revenue fell 17.7% YoY and swung to a loss of ₹15.16 lakh from a profit of ₹57.96 lakh. Full-year profit was a mere ₹11.16 lakh, highlighting fragility.

Opportunities (10)

  • Analog Devices (ADI) / Cyclical Recovery Play (OPPORTUNITY)

    Revenue up 37% YoY with Industrial (+56%) and Communications (+79%) segments leading. Trading at a potential discount given the magnitude of the recovery. Severance costs ($29.1M) suggest restructuring is complete, setting stage for margin expansion.

  • Consolidated revenue up 18% YoY, EBITDA up 31%, with occupancy at 68% and ARPIP up 9%. The divestment of Apollo Specialty Hospitals and Apollo Fertility for ₹15,500M EV unlocks value and sharpens focus.

  • Record Q1 revenue of $19.5M (+39% YoY), AUM of $3.4B, and $1.9B in transaction volume. The pending SPAC merger with Cantor Equity Partners II (CEPT) provides a public listing catalyst.

  • Morgan Stanley Solana & Ethereum Trusts / Institutional Crypto Access (OPPORTUNITY)

    Two S-1/A filings for exchange-traded trusts tracking SOL and ETH, with staking rewards. These products could unlock significant institutional capital flows into the underlying assets.

  • Filed S-1 for IPO of 6M shares at $24-26, listing on Nasdaq. Nuclear energy is a high-growth thematic area, and this IPO provides early-stage exposure.

  • IPO of 20M units at $10.00, with warrants. Blank check companies with no target offer a near-risk-free arbitrage opportunity if held to redemption, though dilution from founder shares (5.75M at $0.004) is a risk.

  • Buyback of up to ₹18 Cr at ₹328/share (8.53% of capital) via tender offer. This provides a direct price floor and signals management's view of undervaluation. Record date May 18, 2026.

  • Net loss improved 69% YoY, operating loss improved 69.7%, and gross profit grew 23.6% despite lower revenue. Cost restructuring is working; if revenue stabilizes, profitability could follow.

  • Issued $160M in first mortgage bonds with tranches at 4.77% (due 2029) and 6.10% (due 2056). The 6.10% yield on a 30-year utility bond is attractive in the current rate environment, secured by substantially all property.

  • Entered a $3.75B revolving credit facility with favorable pricing (0.875% to 1.500% over SOFR based on credit ratings). The facility strengthens the balance sheet of a critical energy infrastructure player.

Sector Themes (6)

  • Micro-Cap Distress Wave

    5 of 50 filings (Powerdyne, Renewal Fuels, AppYea, USA Opportunity Income, Starfighters Space) show severe liquidity crises, widening losses, and going-concern risks. This suggests a broader capital drought for unprofitable micro-caps, likely driven by rising interest rates and risk aversion. Investors should avoid or short this cohort.

  • Institutional Crypto Infrastructure Build

    Three filings (Morgan Stanley Solana Trust, Morgan Stanley Ethereum Trust, Securitize Holdings) focus on creating institutional-grade crypto access products. This theme signals a maturing asset class with significant potential for capital inflows, particularly via staking rewards.

  • Healthcare Demand Resilience

    Apollo Hospitals and Haemonetics both show strong demand signals. Apollo's 18% revenue growth and 31% EBITDA growth contrast with Haemonetics' 42% net income drop, but the latter's 400 bps gross margin expansion to 59% indicates pricing power. The sector shows bifurcation between volume-driven and margin-driven players.

  • SPAC Activity Resurgence

    Three SPAC-related filings (FutureCorp Space Acquisition 1 IPO, Evernorth Holdings/Armada Acquisition II, Securitize/Cantor Equity Partners II) indicate a revival in SPAC activity. However, the lack of targets and high dilution risk (FutureCorp's founder shares at $0.004) suggest caution is warranted.

  • Energy Sector Divergence

    PrimeEnergy Resources' 52.5% net income decline and negative natural gas revenue contrast with the broader energy infrastructure strength seen in Northwest Pipeline's $3.75B credit facility. This highlights the divergence between E&P companies exposed to volatile commodity prices and stable midstream infrastructure.

  • Capital Allocation Shift to Debt Management

    Multiple filings (Avista Corp, Northwest Pipeline, Sachem Capital) focus on debt refinancing and credit facilities. This suggests a macro environment where companies are prioritizing liquidity and balance sheet strength over aggressive growth or buybacks, likely in anticipation of higher-for-longer interest rates.

Watch List (8)

  • Society Pass Inc. (SOPA)
    👁

    Nasdaq delisting effective May 21, 2026. Monitor appeal outcome and Chapter 11 proceedings for potential recovery or total loss. [May 21, 2026]

  • Board meeting on May 26, 2026 to approve Q4 FY26 results. Trading window closed since April 1. Results will provide clarity on full-year performance. [May 26, 2026]

  • 16th CoC meeting on May 26, 2026 to approve audited results. Under insolvency, this meeting could signal progress toward resolution or further delays. [May 26, 2026]

  • NCLT hearing on Resolution Plan approval rescheduled to June 2, 2026. A positive outcome could unlock value for creditors; further delays increase risk. [June 2, 2026]

  • Pending business combination expected to close H1 2026. Monitor for shareholder vote and SEC effectiveness of registration statement. [H1 2026]

  • Record date for final dividend (₹10/share) is August 14, 2026. AGM and dividend payment on or before September 10, 2026. Watch for any changes to dividend policy. [August 14, 2026]

  • S-1 filed for Nasdaq listing under 'FISN'. Monitor for pricing and first-day trading performance. The $24-26 range will test investor appetite for nuclear energy.

  • New CFO Massimo Andolina takes over August 1, 2026. Watch for any strategic shifts, especially regarding smoke-free product investment and capital allocation. [August 1, 2026]

Filing Analyses (50)
PRIMEENERGY RESOURCES CORP 10-Q mixed materiality 8/10

20-05-2026

PrimeEnergy Resources reported a 52.5% decline in net income for Q1 2026 to $4.3M vs $9.1M in Q1 2025, driven by a steep loss in natural gas revenues and a $1.94M unrealized derivative loss. Total revenues fell 21.3% to $39.4M, though oil sales grew 8.3% to $35.4M. The company improved cash and cash equivalents to $19.4M from $7.4M at year-end 2025, but operating cash flow dropped 57.9% to $16.1M.

  • · Natural gas revenue turned negative at -$1.02M in Q1 2026, compared to +$6.03M in Q1 2025, likely due to unfavorable pricing or hedging settlements.
  • · Natural gas liquids revenue fell 39.3% to $5.18M from $8.53M.
  • · A $1.94M unrealized loss on derivative instruments was recorded in Q1 2026, with no such loss in Q1 2025.
  • · Field service revenue declined 16.7% to $1.79M and field service expenses dropped 36.5% to $1.18M.
  • · Gain on disposition of assets was only $16K vs $619K in the prior year.
  • · Property expenditures plummeted 95.7% to $1.5M from $34.7M, indicating significantly reduced capital spending.
  • · The company had no long-term bank debt in Q1 2026 vs $24M borrowed and $21.5M repaid in Q1 2025.
  • · Deferred income taxes swung to a benefit of $3.1M in Q1 2026 from a provision of $2.0M in Q1 2025.
  • · Accrued liabilities increased slightly to $26.7M from $26.2M, but compensation-related accruals dropped significantly from $10.7M to $4.8M.
  • · Accounts payable fell to $7.6M from $11.0M, driven by a $3.4M decline in trade payables.
  • · Total equity rose slightly to $217.4M from $215.7M, mostly from net income partially offset by treasury stock purchases.
Morgan Stanley Solana Trust S-1/A neutral materiality 7/10

20-05-2026

Morgan Stanley Solana Trust, a Delaware-based grantor trust, filed Amendment No. 1 to Form S-1 on May 20, 2026, to register common shares of beneficial interest (Shares) for an exchange-traded fund listed on NYSE Arca. The trust seeks to passively track the performance of SOL (the native token of Solana) using the CoinDesk Solana Benchmark 4PM NY Settlement Rate, and will also engage in staking a portion of its SOL to generate rewards, distributing them monthly. The filing details the roles of Morgan Stanley Investment Management Inc. as Delegated Sponsor, CSC Delaware Trust Company and AGS Trustees as trustees, and BNY Mellon and Coinbase Custody Trust Company as SOL custodians, with cash creations and redemptions facilitated through Authorized Participants and SOL Counterparties.

  • · The trust intends to make monthly (at least quarterly) distributions of staking rewards.
  • · Morgan Stanley Investment Management Inc. (Delegated Sponsor) has discretion to determine whether staking creates undue legal or regulatory risk, including tax qualification risk.
  • · Shares are expected to be listed on NYSE Arca; the trust is a grantor trust for U.S. federal income tax purposes.
  • · Trust will not use leverage, derivatives, or similar instruments.
  • · Authorized Participants can purchase shares with cash (via a SOL Counterparty) or in-kind with SOL; redemptions similarly may be cash or in-kind.
  • · Baskets are 10,000 Shares each; Shares are not redeemable outside Basket aggregations except in liquidation.
  • · The Cayman Trustee is a wholly owned subsidiary of Appleby Global Services (Cayman) Limited, a regulated entity under the Cayman Islands Monetary Authority.
Red Cat Holdings, Inc. 8-K positive materiality 7/10

20-05-2026

Red Cat Holdings, Inc. (RCAT) completed the acquisition of Quaze Technologies Inc., a developer of wireless power transfer technology for unmanned systems, on May 20, 2026. The acquisition addresses a key operational constraint—manual battery swaps and connector-based charging—by enabling autonomous recharging across air, land, and maritime domains. Quaze will operate as an independent business unit and maintain a platform-agnostic model, opening a new revenue channel from third-party systems while strengthening Red Cat's all-domain capabilities.

  • · Quaze is based in Québec, Canada.
  • · The QU6 electronic architecture enables large surfaces to function as wireless energy access points without requiring precise alignment, physical connectors, or direct contact.
  • · The system can operate in the presence of debris, sand, ice, or snow.
  • · Quaze’s technology has been demonstrated across aerial drones, ground systems, and autonomous underwater vehicles.
  • · Red Cat expects Quaze to support expansion into maritime systems and multi-platform autonomy, including swarming, extended ISR missions, and autonomous deployment cycles.
  • · The acquisition introduces a new revenue channel through integration into third-party systems, making Quaze a potential standard for wireless power across the unmanned systems ecosystem.
HAEMONETICS CORP 10-K mixed materiality 9/10

20-05-2026

Haemonetics Corp reported a 2.0% decline in net revenues to $1,334,027K for fiscal year 2026, with a significant 42.0% drop in net income to $97,308K compared to $167,679K in FY2025. While gross profit improved 5.2% to $787,586K and gross margin expanded to 59.0% from 55.0%, operating income fell 29.3% to $156,734K due to a 19.7% increase in operating expenses, driven by a $86,546K impairment of intangible assets. Segment performance was mixed: Hospital net revenues grew 4.3% (led by Blood Management Technologies +14.6%), but Plasma revenues declined 2.0% and Blood Center revenues fell 15.3% (Whole Blood -99.2%).

  • · Net debt position worsened to $979,140K from $918,025K in FY2025.
  • · Working capital improved to $552,280K from $356,862K, and current ratio increased to 3.0 from 1.6.
  • · Days sales outstanding remained stable at 56 days vs 55 days.
  • · Inventory turnover improved slightly to 1.5 from 1.4.
  • · Net cash used in investing activities increased to $179,547K from $161,895K.
  • · Financing activities swung to a net use of $178,460K from a net source of $108,818K.
  • · US revenue declined 2.8% (reported) while International revenue grew 0.6% (reported), but constant currency growth was negative for both (US -2.8%, International -2.6%).
  • · Revenue mix shifted: US share decreased to 73.6% from 74.3%, Europe increased to 13.9% from 12.9%, Japan increased to 5.1% from 4.6%.
  • · SG&A expense as a percentage of net revenues increased to 33.2% from 32.1%.
  • · R&D expense as a percentage of net revenues decreased slightly to 4.5% from 4.6%.
ANALOG DEVICES INC 10-Q mixed materiality 8/10

20-05-2026

Analog Devices Inc. (ADI) reported a strong Q2 FY2026 with revenue of $3.62B, up 37% YoY from $2.64B, and net income of $1.18B, more than doubling from $570M. The Industrial segment surged 56% YoY and Communications grew 79%, while Automotive revenue was nearly flat at +2% YoY. The company also recorded $29.1M in new employee severance costs under global repositioning actions during the quarter.

  • · Distributor channel revenue was $2.07B (57% of total) in Q2 FY2026, up from $1.48B (56%) in Q2 FY2025.
  • · Direct customer revenue was $1.52B (42% of total) in Q2 FY2026, up from $1.13B (43%) in Q2 FY2025.
  • · Accrued special charges for global repositioning actions stood at $13.4M at May 2, 2026, down from $31.2M at January 31, 2026, after $17.9M in severance payments during Q2.
  • · Total assets measured at fair value were $2.23B as of May 2, 2026, including $703M in government/institutional money market funds and $398M in corporate obligations (Level 2).
  • · Total liabilities measured at fair value were $33.9M, consisting of forward foreign currency exchange contracts ($10.0M) and interest rate derivatives ($23.9M).
  • · Other comprehensive income for Q2 FY2026 was $2.3M, driven by foreign currency translation gains ($1.3M) and derivative gains ($0.6M).
  • · Provision for income taxes increased to $148.5M in Q2 FY2026 from $56.2M in Q2 FY2025, reflecting higher pre-tax income.
Philip Morris International Inc. 8-K mixed materiality 7/10

20-05-2026

Philip Morris International announced the appointment of Massimo Andolina as Group CFO, effective August 1, 2026, succeeding Emmanuel Babeau, who will remain as Strategic Advisor until March 31, 2027. Andolina, previously President of the Europe Region, led robust top- and bottom-line growth in the region, while Babeau oversaw strong financial performance and the acquisition of Swedish Match during his tenure. The smoke-free business accounted for 43% of Q1 2026 net revenues, but the company faces ongoing risks including regulatory restrictions, excise tax increases, and geopolitical instability.

  • · Andolina joined PMI in 2008 and served as SVP Global Operations from 2018 to 2023, leading a team of over 30,000 people.
  • · Babeau was appointed CFO in May 2020 and led the acquisition of Swedish Match in 2022.
  • · Smoke-free products are available in over 105 markets and used by over 43 million legal-age consumers as of December 31, 2025.
  • · The U.S. FDA has authorized marketing of Swedish Match's General snus and ZYN nicotine pouches, as well as versions of IQOS devices and consumables.
  • · Andolina holds a Master of Science in Mechanical and Industrial Engineering from the University of Palermo and an MBA from IMD in Lausanne.
Milkfood Ltd. Default mixed materiality 7/10

20-05-2026

Milkfood Ltd. has announced a second 100-day campaign called 'Saksham Niveshak' from April 1, 2026 to July 9, 2026, urging shareholders to update KYC, bank account details, nominee, and contact information to claim unpaid/unclaimed dividends and prevent transfer of shares and dividends to the Investor Education and Protection Fund (IEPF). The company also published its audited consolidated and standalone financial results for the quarter and year ended March 31, 2026, showing a significant increase in net profit after tax to ₹5,405.90 lakh (standalone) and ₹5,881.88 lakh (consolidated) for the year, compared to ₹4,613.34 lakh and ₹5,127.87 lakh respectively in the prior year. However, the standalone quarterly net profit after tax showed a sharp decline to a loss of ₹1,063.91 lakh for the quarter ended March 31, 2026, versus a profit of ₹66.23 lakh in the same quarter last year, indicating mixed performance.

  • · The Board of Directors recommended a final dividend of ₹3.85 per share (previous year ₹3.15 per share), subject to shareholder approval at the AGM.
  • · The company issued 2,00,00,000 equity shares of ₹10 each to the promoter company on February 21, 2026, pursuant to an NCLT-approved restructuring plan.
  • · Standalone total comprehensive income for the year ended March 31, 2026 was ₹5,486.87 lakh, up from ₹4,587.77 lakh in FY25.
  • · Consolidated total comprehensive income for the year ended March 31, 2026 was ₹5,004.30 lakh, down from ₹5,400.55 lakh in FY25, showing a decline of 7.3%.
  • · The standalone quarterly total comprehensive loss for Q4 FY26 was ₹3,438.84 lakh, compared to a profit of ₹66.23 lakh in Q4 FY25.
  • · The company revalued its property, plant and equipment (PPE) of Sivassa and Bankirs units on March 27, 2026, with the revaluation surplus credited to Revaluation Reserve.
  • · The statutory auditors issued an unmodified audit report on the quarterly and annual financial results.
AVISTA CORP 8-K mixed materiality 7/10

20-05-2026

Avista Corp. issued $160M in first mortgage bonds ($90M at 4.77% due 2029, $70M at 6.10% due 2056) on May 14, 2026, with an additional $70M of 6.10% bonds expected in August 2026, to refinance debt and fund capital expenditures. At the 2026 Annual Meeting, shareholders approved the election of all 11 directors, ratification of Deloitte & Touche as auditor, and an advisory vote on executive compensation; however, a proposal to reduce the shareholder approval threshold from 80% to a majority failed to receive the required 80% affirmative vote.

  • · The bonds are secured by a lien on substantially all property of the Company (except excepted property) under the Mortgage and Deed of Trust dated June 1, 1939.
  • · The bonds are redeemable prior to maturity at the Company's option with a make-whole premium plus accrued interest; bonds held by specified foreign entities are redeemable at 100% of principal plus accrued interest.
  • · Proposal 4 (amendment to reduce shareholder approval requirement from 80% to a majority) failed, receiving 64,317,253 votes for, 805,879 against, and 325,048 abstentions, but not reaching the 80% threshold of outstanding shares.
  • · Director Janet D. Widmann received the lowest support among nominees with 58,951,492 votes for and 6,351,486 against.
  • · The bonds were issued in the private placement market and are not registered under the Securities Act of 1933.
Unknown Default materiality 6/10

20-05-2026

CHOICEONE FINANCIAL SERVICES INC 8-K mixed materiality 7/10

20-05-2026

ChoiceOne Financial Services, Inc. held its 39th Annual Shareholder Meeting on May 20, 2026, presenting financial results and strategic updates. The company reported total assets of $4.4B, deposits of $3.7B, and gross loans of $3.0B as of March 31, 2026. Adjusted net income grew to $28.2M in 2025 from $26.7M in 2024, while adjusted basic EPS rose to $3.70 from $3.40. However, Q1 2026 adjusted net income dropped sharply to $1.0M, and adjusted basic EPS fell to $0.91, reflecting a significant decline from the prior year.

  • · The company has 54 locations throughout Michigan.
  • · Community donations exceeded $604,000 and volunteer hours exceeded 8,000 as of December 31, 2025.
  • · The merger with Fentura Financial Inc. added $1.8B in assets, $1.4B in loans, $1.4B in deposits, and $193M in equity in 2025.
  • · Cash dividends per share increased steadily from $0.94 in 2021 to $1.13 in 2025, with a dividend yield of 3.8% as of December 31, 2025.
  • · The company's mobile app has a 4.7-star rating on the Apple App Store.
  • · ChoiceOne was recognized as SBA Michigan 504 Third Party Lender of the Year for fiscal year 2023 and received the MBA Innovator of the Year award in 2025.
Onward Technologies Limited Buyback neutral materiality 6/10

20-05-2026

Onward Technologies Limited announced a buyback of up to 5,48,780 equity shares at ₹328 per share for an aggregate consideration not exceeding ₹18 Crore. The buyback opens on May 22, 2026, and closes on May 29, 2026, with a record date of May 18, 2026, and is conducted via the tender offer route through stock exchange mechanism. The buyback represents 8.53% (standalone) and 7.49% (consolidated) of the aggregate of paid-up equity share capital and free reserves, well within the statutory limit of 10%.

  • · Record date for determining eligible shareholders is May 18, 2026.
  • · Small Shareholders reserved category entitlement ratio: 39 equity shares for every 985 shares held; General category: 34 equity shares for every 859 shares held.
  • · Actual entitlement factors: Small Shareholders 0.039594701; General Category 0.039581355.
  • · Buyback is through tender offer route via stock exchange mechanism on a proportionate basis.
  • · Manager to the Buyback: Centrum Broking Limited; Registrar: MUFG Intime India Private Limited.
  • · No cash outflow beyond ₹18 Crore (excluding transaction costs).
  • · No period-over-period comparisons are provided in the filing (only current buyback details).
Apollo Hospitals Enterprise Limited Board Meeting mixed materiality 9/10

20-05-2026

Apollo Hospitals Enterprise Limited reported standalone revenue from operations of ₹93,262 million for FY2025-26, up 13.7% from ₹82,021 million in the prior year, and profit after tax of ₹14,926 million, up 15.1% from ₹12,963 million. However, the board also approved a transaction to divest its stake in Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited at an enterprise value of approximately ₹15,500 million, and approved the merger of wholly owned subsidiary Apollo Hospitals North Ltd into the company. A final dividend of ₹10 per share (200% of face value) was recommended.

  • · The board declared that the statutory auditors have issued audit reports with unmodified opinion on the financial statements.
  • · The record date for the final dividend and AGM is fixed as August 14, 2026.
  • · The dividend, if approved, will be paid on or before September 10, 2026.
  • · Dr. Prathap C Reddy was re-appointed as Executive Chairman for two years from June 25, 2026, subject to shareholder approval.
  • · Ms. Rama Bijapurkar was re-appointed as Independent Director for a second term of five years from November 12, 2026 to November 11, 2031, subject to shareholder approval by special resolution.
  • · The company's credit ratings are AAA (ICRA Ltd) and AA+ (Crisil Ltd).
  • · No borrowings were made by way of issuance of debt securities during the year.
  • · The standalone balance sheet shows total assets of ₹149,144 million as of March 31, 2026, up from ₹133,723 million a year earlier.
  • · Net cash generated from operating activities was ₹20,591 million for FY2025-26, compared to ₹17,419 million in the prior year.
DCM Shriram Fine Chemicals Ltd Regulatory Action negative materiality 8/10

20-05-2026

DCM Shriram Fine Chemicals Ltd reported a net loss of ₹408 Lakh for Q4 FY26, compared to a profit of ₹427 Lakh in Q4 FY25, while full-year net profit fell sharply to ₹429 Lakh from ₹1,845 Lakh in FY25. Total income from operations declined 17.8% YoY in Q4 and 10.3% for the full year. The results reflect the impact of a composite scheme of arrangement that became effective in December 2025, which included the transfer of net assets and the issuance of new equity shares.

  • · The Board recommended a final dividend of ₹0.40 per equity share (face value ₹2 each) for FY26, subject to shareholder approval.
  • · The Company reversed an excess impairment loss of ₹223 Lakh on leasehold land in Dahej, Gujarat, and also reversed input tax credit of ₹229.02 Lakh due to withdrawal of a GST refund application.
  • · The Company assessed the new Labour Codes and concluded there is no material financial impact based on existing remuneration structure.
  • · The Scheme of Arrangement resulted in Daurala Foods and Beverages Private Limited becoming a wholly owned subsidiary of the Company.
  • · The Company's business is a single primary segment: manufacturing of Organics and fine chemicals in India.
APPYEA, INC 10-Q negative materiality 8/10

20-05-2026

AppYea, Inc. reported a net loss of $1.568M for Q1 2026, a significant increase from a $0.166M loss in Q1 2025, driven by higher operating expenses and a $0.386M change in fair value of derivative liabilities. The company had zero revenue in Q1 2026 compared to $3K in Q1 2025, and its accumulated deficit grew to $27.023M. However, cash and cash equivalents more than doubled to $0.811M from $0.408M at year-end 2025, supported by $0.698M in financing proceeds from stock issuances.

  • · Total assets decreased slightly to $21.541M as of March 31, 2026 from $21.733M at December 31, 2025.
  • · Total liabilities increased to $9.726M from $8.798M, primarily due to a $0.734M increase in derivative liability.
  • · Stockholders' equity decreased to $11.815M from $12.935M, driven by the net loss.
  • · Operating loss widened to $1.184M from $0.123M in Q1 2025, mainly due to $0.533M in amortization of intangible assets and higher G&A expenses.
  • · The company issued 34,090,910 shares to investors in Q1 2026, raising $0.372M.
  • · Net cash used in operating activities was $0.297M in Q1 2026 vs $0.103M in Q1 2025.
  • · The company has a going concern uncertainty (Note 1D).
  • · On August 20, 2025, AppYea acquired proprietary blockchain-based lottery and gaming technology from Techlott Enterprises Ltd. in exchange for common stock.
ConnectOne Bancorp, Inc. 8-K positive materiality 6/10

20-05-2026

ConnectOne Bancorp, Inc. held its Annual Meeting on May 19, 2026, where shareholders elected 15 directors, approved the 2026 Equity Incentive Plan, and ratified the independent auditor. The board also appointed Elizabeth Magennis as President of the Registrant, while Frank Sorrentino continues as Chairman and CEO. All proposals passed with strong support, though broker non-votes were significant at 6,162,210 shares.

  • · Proposal 1: All 15 directors were elected with votes For ranging from 34,914,271 to 35,699,832; highest withheld votes were for Frank Huttle III (1,216,630) and Frank W. Baier (1,011,078).
  • · Proposal 2 (2026 Equity Incentive Plan): 34,424,591 For, 1,648,967 Against, 57,343 Abstentions.
  • · Proposal 3 (Advisory Say-on-Pay): 34,932,239 For, 774,603 Against, 424,059 Abstentions.
  • · Proposal 4 (Ratification of Auditors): 41,871,092 For, 377,047 Against, 44,972 Abstentions — no broker non-votes as this is a routine matter.
  • · Elizabeth Magennis was previously Executive Vice President of the Registrant and President of ConnectOne Bank; she will continue as President of the Bank and as a director of both entities.
  • · Frank Sorrentino relinquished the President title but remains Chairman and CEO.
Devinsu Trading Ltd. Open Offer materiality 6/10

20-05-2026

Apollo Hospitals Enterprise Limited Company Update mixed materiality 8/10

20-05-2026

Apollo Hospitals Enterprise Limited reported consolidated revenue of ₹66,055 Mio for Q4 FY26, up 18% YoY, and EBITDA of ₹10,109 Mio (15.3% margin), up 31% YoY. However, the Digital Health segment (Apollo HealthCo) posted a cash loss of ₹16 Cr for the quarter (excluding ESOP charges), and the Online Pharmacy Distribution segment reported an EBITDA loss of ₹391 Mio vs. a loss of ₹1,253 Mio in Q4 FY25. Overall PAT grew 36% YoY to ₹5,292 Mio, but Healthcare Services PAT growth was only 7% due to tax reversals in the prior year.

  • · Healthcare Services segment reported 156,728 in-patients in Q4 FY26, up 7% YoY.
  • · Average Revenue per In-patient (ARPIP) was ₹187,208, up 9% YoY.
  • · Overall occupancy was 68%, with established units at 69%.
  • · Apollo 24|7 had 47 Mn+ registered users and ~9 Lacs daily active users.
  • · Offline Pharmacy Distribution operated 7,289 stores as of March 31, 2026.
  • · Online Pharmacy Distribution EBITDA loss narrowed to ₹391 Mio from ₹1,253 Mio in Q4 FY25.
  • · AHLL's Mother & Child and Fertility businesses valued at INR 1,550 Crore in a combination of cash and 9.9% equity stake in the combined entity (subject to CII approval).
  • · AHLL operates 316 clinics, 2,501 diagnostics centers, 167 dialysis centers, and 280 dental centers.
  • · Consolidated revenue for FY26 was ₹252,285 Mio (up 16% YoY), EBITDA ₹37,693 Mio (up 25% YoY), PAT ₹19,415 Mio (up 34% YoY).
  • · Healthcare Services PAT growth of 7% in Q4 FY26 was impacted by tax reversals/adjustments in Q4 FY25.
Unknown Monetary Policy materiality 6/10

20-05-2026

Fine Organic Industries Limited Regulatory Action neutral materiality 4/10

20-05-2026

Fine Organic Industries Limited released its May 2026 investor presentation, highlighting its position as a leading global producer of oleochemical-based specialty additives for foods, polymers, feeds, cosmetics, and coatings. The company reported a workforce of 930+ employees, serves over 5,400 end-users across 110+ countries, and emphasizes green chemistry and sustainability. However, the filing does not include any financial performance data, period-over-period comparisons, or specific growth metrics, limiting the ability to assess current business trends.

  • · The company has over 50 years of history, starting as a partnership firm in 1970 and incorporating as Fine Organic Industries in 1973.
  • · R&D centre established in Navi Mumbai (2008-2012) and a dedicated R&D centre (Fine Research & Development Centre Pvt. Ltd.) commissioned in 2014-2015.
  • · Wholly owned subsidiaries: Fine Organics Americas LLC (USA), Fine Organics FZE (UAE), Fine Europe (Mumbai) Pvt. Ltd., and Fine Specialty Surfactants Pvt. Ltd.
  • · Joint venture in Thailand (JVC) commenced production in 2022-2026.
  • · Women employees constitute 19% of the workforce; over 10% of employees have completed more than 25 years; over 9% are second-generation employees.
  • · The company has fully automated production facilities and multiple production sites.
  • · Board includes 11 directors, with Shailendra Nadkarni appointed as Independent Director effective May 19, 2026 (subject to shareholder approval).
USA OPPORTUNITY INCOME ONE, INC. 10-Q negative materiality 8/10

20-05-2026

USA OPPORTUNITY INCOME ONE, INC. reported a net loss of $66,823 for Q1 2026, widening from a $45,592 loss in Q1 2025, driven by higher operating expenses. Total assets increased to $34,359 from $4,995 at year-end 2025, while total liabilities rose to $927,244 from $831,057. The company has no revenue and continues to rely on debt and related-party advances.

  • · General & administrative expense increased to $60,031 in Q1 2026 from $39,790 in Q1 2025.
  • · Interest expense on bonds rose to $6,792 in Q1 2026 from $5,867 in Q1 2025.
  • · Unrestricted cash increased to $34,359 as of March 31, 2026 from $4,995 as of December 31, 2025.
  • · Accounts payable increased to $37,245 as of March 31, 2026 from $16,058 as of December 31, 2025.
  • · Bonds issued and outstanding at par total $260,000 as of March 31, 2026 (current $170,000 + non-current $90,000).
  • · The company has no revenue and no provision for income taxes.
  • · Net loss per share was $(22.27) for Q1 2026 versus $(15.20) for Q1 2025.
  • · Stockholders' deficit worsened to $(892,885) from $(826,062) at year-end 2025.
  • · Principal repayment schedule shows $150,000 due in 2026, $45,000 in 2027, $65,000 in 2029.
Skillz Inc. 8-K neutral materiality 6/10

20-05-2026

On May 17, 2026, Skillz Inc. appointed Robert Alex Walsh as its new Chief Financial Officer, effective July 13, 2026, succeeding Gaetano Franceschi who will transition to an advisory role through September 30, 2026. Mr. Walsh most recently served as CFO of Aristocrat Gaming and brings substantial finance experience from LEGO and Procter & Gamble. His compensation package includes a $450,000 base salary, target incentive compensation of $450,000 annually ($400,000 for 2026), and RSU/PSU awards valued at $200,000 each. The outgoing CFO Gaetano Franceschi, who had been in transition since a December 2025 separation agreement, will provide advisory services through September 30, 2026.

  • · Robert Alex Walsh, 41, previously served as CFO of Aristocrat Gaming (largest segment of Aristocrat Leisure Limited) since December 2024, and prior as SVP of Finance – Americas and EMEA at Aristocrat since January 2022.
  • · Walsh holds a Bachelor of Science in Business Economics from Indiana University and a Master of Business Administration in Finance from Xavier University.
  • · RSUs vest 33% on the first anniversary and then in 8 equal quarterly installments, achieving full vesting after three years.
  • · PSU award has a three-year performance period from July 13, 2026 to July 12, 2029, with vesting subject to Company goals and continued service.
  • · Outgoing CFO Gaetano Franceschi's last day was initially set per a December 2025 separation agreement, extended by a March 2026 side letter until October 1, 2026 or mutually agreed date; he will now serve in an advisory capacity from the Effective Date (July 13, 2026) through September 30, 2026.
  • · No family relationships or reportable transactions exist between Walsh and the Company's directors or executive officers.
Securitize Holdings, Inc. 425 mixed materiality 8/10

20-05-2026

Securitize reported Q1 2026 revenue of $19.5M, up 39% YoY and the highest quarterly revenue in company history, driven by growth in tokenized asset services. However, Adjusted EBITDA fell sharply to $0.8M from $4.1M in the prior year, and net loss widened to $7.9M ($0.88 per diluted share). The company also highlighted key partnerships with NYSE, Uniswap Labs, and Computershare, and noted the pending business combination with Cantor Equity Partners II (CEPT) is expected to close in H1 2026.

  • · Net loss per diluted share was $0.88 in Q1 2026.
  • · Average AUM in Q1 2026 was $3.2B, with AUM of $3.4B as of March 31, 2026.
  • · Aggregated Transaction Volume in Q1 2026 was $1.9B.
  • · 650 active funds were serviced by Securitize Fund Services as of March 31, 2026.
  • · AUA was $24.9B as of March 31, 2026.
  • · The tokenized real-world asset market grew from ~$23B (Dec 31, 2025) to $31B (Mar 31, 2026), ~35% growth.
  • · Securitize was named design partner and first digital transfer agent for the NYSE Digital Trading Platform.
  • · Securitize was chosen to tokenize loan interests tied to Trump International Hotel & Resort, Maldives.
  • · The business combination with CEPT is expected to close in H1 2026, subject to regulatory and shareholder approvals.
  • · Securitize ended Q1 2026 with approximately breakeven operating cash flow before working capital movements and public-company related expenses.
POWERDYNE INTERNATIONAL, INC. 10-Q negative materiality 8/10

20-05-2026

POWERDYNE INTERNATIONAL, INC. reported a net loss of $120,246 for Q1 2026, more than doubling the $55,134 loss in Q1 2025, as revenue declined 36.9% to $171,025 from $271,056. The company's cash position fell sharply to $24,271 from $47,382 at year-end 2025, while total assets decreased to $318,152 from $341,922. Stockholders' deficit widened to ($507,700) from ($504,954), and the company continues to rely on related-party loans and a line of credit for financing.

  • · Trade accounts receivable plummeted to $4,334 at March 31, 2026 from $76,018 at December 31, 2025, a 94.3% decline.
  • · Inventories decreased to $66,182 from $94,555, a 30.0% drop.
  • · Accounts payable and accrued expenses fell to $56,950 from $109,742, a 48.1% reduction.
  • · Due to related party - CEO increased to $273,591 from $250,591, a 9.2% rise.
  • · Loans from related parties grew to $64,500 from $40,000, a 61.3% increase.
  • · Operating cash flow used was $70,611 in Q1 2026, improving from $84,504 used in Q1 2025.
  • · Financing activities provided $47,500 in Q1 2026, primarily from related-party loans.
  • · The company issued 25,000,000 common shares for services valued at $117,500 during Q1 2026.
  • · Basic and diluted loss per share remained $0.00 for both periods due to the high share count.
  • · The company had a working capital deficit of $507,700 at March 31, 2026 (current liabilities of $771,302 vs current assets of $263,602).
Plum Acquisition Corp. III 10-Q mixed materiality 6/10

20-05-2026

Plum Acquisition Corp. III reported a net income of $4.4M for Q1 2026, a significant turnaround from a net loss of $364,540 in Q1 2025, driven primarily by a $4.6M gain on the change in fair value of warrant liabilities. However, operating losses improved but remained negative at $237,912 (vs. $532,731 in Q1 2025), and cash dropped sharply from $49,870 to just $438, while total assets declined from $579,291 to $531,391.

  • · The company is a shell company and an emerging growth company.
  • · Class A ordinary shares subject to possible redemption were 42,486 shares at a redemption value of approximately $11.72 per share as of March 31, 2026 (vs. $11.64 at December 31, 2025).
  • · Net cash used in operating activities improved to $89,432 in Q1 2026 from $285,965 in Q1 2025.
  • · No cash was provided by investing activities in Q1 2026, compared to $23,977,494 in Q1 2025 (which included $23,975,464 transferred from Trust Account to pay redeeming shareholders).
  • · Proceeds from promissory note - related party were $40,000 in Q1 2026 vs. $350,000 in Q1 2025.
  • · Total current liabilities increased slightly to $6,212,409 as of March 31, 2026 from $6,025,804 as of December 31, 2025.
  • · Accumulated deficit improved to $8,134,378 as of March 31, 2026 from $12,527,667 as of December 31, 2025.
  • · Basic and diluted net income per share for both redeemable and non-redeemable shares was $0.55 in Q1 2026, compared to a loss of $0.04 per share in Q1 2025.
NORTHWEST PIPELINE LLC 8-K positive materiality 8/10

20-05-2026

Northwest Pipeline LLC, along with The Williams Companies, Inc. and Transcontinental Gas Pipe Line Company, LLC, entered into a $3,750,000,000 Senior Unsecured Revolving Credit Facility dated May 19, 2026, with Wells Fargo Bank as Administrative Agent and a syndicate of major banks. The agreement amends and restates a prior credit facility. The applicable interest rate spreads and commitment fees are determined based on the Index Debt ratings of The Williams Companies, Inc., ranging from 0.875% (Term SOFR) for A/A2 rated debt to 1.500% for BBB-/Baa3 rated debt, with no negative financial covenant limits or declines reported.

  • · The borrowers are The Williams Companies, Inc., Northwest Pipeline LLC, and Transcontinental Gas Pipe Line Company, LLC.
  • · Wells Fargo Bank, National Association serves as Administrative Agent, with Wells Fargo Securities, LLC and Citibank, N.A. as Joint Lead Arrangers and Joint Bookrunners.
  • · The facility matures on a date to be determined per extension options (Section 2.04), with no specific maturity date disclosed in the filing excerpt.
  • · The Alternate Base Rate is defined as the greatest of Prime Rate, Federal Funds Effective Rate plus 0.5%, and Term SOFR for one-month plus 1%, subject to a 1% floor.
  • · The facility is used for general corporate purposes, as indicated in Section 5.08, and is unsecured.
KonaTel, Inc. 10-Q mixed materiality 7/10

20-05-2026

KonaTel, Inc. reported a net loss of $282,590 for Q1 2026, a significant improvement from the $917,528 net loss in Q1 2025. Revenue declined 12.2% to $1,905,062 from $2,168,714 in the prior year period, but gross profit improved 23.6% to $805,604 due to a sharp reduction in cost of revenue. The company's cash position decreased to $665,068 from $704,867 at year-end 2025, and total stockholders' equity fell to $196,220 from $384,205.

  • · Operating loss improved to $281,215 from $929,645 in Q1 2025, a 69.7% improvement.
  • · Cost of Revenue decreased 27.5% to $1,099,458 from $1,516,821, driving the gross profit improvement despite lower revenue.
  • · Payroll and Related Expenses decreased 30.9% to $601,643 from $871,362.
  • · Stock Option Expense decreased 60.5% to $94,605 from $239,337.
  • · Professional and Other Expenses decreased 46.7% to $83,942 from $157,431.
  • · Cash used in operating activities was $39,650 in Q1 2026, compared to cash provided by operations of $269,037 in Q1 2025.
  • · Accounts Receivable decreased 49.7% to $142,884 from $284,167, providing $121,781 in operating cash flow.
  • · Total liabilities increased slightly to $2,090,251 from $2,080,074.
  • · The company's accumulated deficit grew to $10,366,733 from $10,084,143.
  • · No income tax expense was recorded for either period.
Vivos Therapeutics, Inc. 10-Q mixed materiality 8/10

20-05-2026

Vivos Therapeutics reported Q1 2026 revenue of $5.141M, up 70.5% YoY from $3.016M, driven by a 207.6% surge in service revenue to $3.701M. However, net loss widened to $7.751M from $3.864M, and operating loss increased to $6.615M from $3.918M. Cash used in operations was $6.010M, up from $3.796M. The company ended the quarter with $2.110M in cash, slightly up from $2.029M at year-end 2025, but total liabilities exceeded total assets, resulting in a stockholders' deficit of $1.267M.

  • · Gross profit improved to $3.059M from $1.509M, a 102.7% increase.
  • · Other expense surged to $1.167M from $4K, primarily due to interest and financing costs.
  • · Net loss per share widened to $0.52 from $0.45.
  • · The company issued 1,819,072 shares upon conversion of debt to common stock.
  • · Proceeds from exercise of warrants were $4.639M.
  • · Non-cash financing activities included conversion of promissory note of $1.540M and conversion of debt to common stock of $0.700M.
  • · Cash paid for interest was $340K in Q1 2026 vs. $0 in Q1 2025.
  • · The company had an accumulated deficit of $133.039M as of March 31, 2026.
  • · Total liabilities decreased slightly to $26.310M from $26.702M, but still exceed total assets, resulting in a negative equity position.
  • · The company's business model is shifting from dentist-focused to medical-provider focused, including the acquisition of SCN in June 2025.
Evernorth Holdings Inc. 425 mixed materiality 6/10

20-05-2026

Evernorth Holdings Inc. released a detailed communication regarding its proposed business combination with Armada Acquisition Corp. II (SPAC) and Pathfinder Digital Assets LLC, as announced on October 19, 2025. The communication is an educational piece by Chief Business Officer Sagar Shah explaining why RLUSD (a stablecoin) cannot replace XRP in the XRP Ledger's decentralized trading infrastructure, arguing that both assets serve distinct and complementary functions. The filing does not provide financial results, but it reaffirms the forward-looking strategy of building on-chain finance routing infrastructure using XRP, while cautioning that these views are subject to significant uncertainty.

  • · The Business Combination Agreement was signed on October 19, 2025, with a Registration Statement (including preliminary proxy statement/prospectus) filed on March 18, 2026, which is not yet effective.
  • · Evernorth identifies three structural reasons why RLUSD cannot replace XRP as the routing asset: (1) stablecoins have issuer risk / single point of failure; (2) stablecoins must comply with sanctions, freeze tokens, and restrict jurisdictions, undermining neutrality; (3) liquidity pools on a DEX require two distinct assets, so a non-stablecoin bridge asset is always needed.
  • · XRP is cited as having 'years of operating history without interruption', deep liquidity, and no issuer that can censor or freeze the asset — key features for its role as a bridge/collateral/escrow asset.
  • · The filing includes a forward-looking statement caveat that there can be no assurance the anticipated development of on-chain finance will occur as expected.
Cenntro Inc. 8-K neutral materiality 6/10

20-05-2026

Cenntro Inc. entered into securities purchase agreements on May 12, 2026, to issue 1,000,000 shares of common stock at $3.93 per share in a private placement, expecting gross proceeds of approximately $3.93 million. The proceeds are intended for working capital and general corporate purposes. However, as of the filing date, closing conditions have not been satisfied and no shares have been issued, indicating the transaction remains pending.

  • · The purchase price of $3.93 per share equals the closing price on the same day.
  • · The offering is conducted under Nasdaq Listing Rule 5635(d), allowing issuances of 20% or more of outstanding common stock without shareholder approval.
  • · On May 19, 2026, the parties amended the agreement to allow subscription in stablecoins.
  • · The private placement is exempt from registration under Section 4(a)(2) of the Securities Act and Regulation S.
  • · Each investor must represent it is not a 'U.S. person' under Regulation S.
  • · The shares have not been registered and are subject to transfer restrictions with a restrictive legend.
WILLAMETTE VALLEY VINEYARDS INC 8-K neutral materiality 4/10

20-05-2026

Willamette Valley Vineyards, Inc. appointed John Hazlett as Chief Financial Officer effective May 20, 2026, replacing John Ferry who announced his retirement on February 12, 2026. Mr. Hazlett will receive a base salary of $216,000 per year and is eligible for an annual performance-based incentive of up to $24,000. The transition period for Mr. Ferry has not yet been determined.

  • · Mr. Hazlett, 51, has served as founding partner of Trailwise Advisory Services since January 2025.
  • · He previously served as CFO of RENA Technologies North America (Dec 2021–Dec 2024) and Climax Portable Machine Tools (Mar 2018–Mar 2020).
  • · He holds an MBA from Baldwin Wallace University and a BS in Accounting and Finance from Bowling Green State University, and maintains an active CPA license in Ohio.
  • · Mr. Hazlett has no family relationships with any current director, director nominee, or executive officer of the Company.
  • · The employment agreement is dated May 19, 2026, and performance goals will be established annually by the Company’s President.
Renewal Fuels, Inc. 10-Q negative materiality 8/10

20-05-2026

Renewal Fuels, Inc. (RNWF) reported a net loss of $669,750 for Q1 2026, a significant increase from the $100,000 loss in Q1 2025, driven by a surge in operating expenses to $632,583 from $100,000. Cash and cash equivalents rose sharply to $99,594 from $2,525 at year-end 2025, primarily due to $513,000 in proceeds from prepaid warrants. However, the company remains deeply insolvent with a stockholders' deficit of $1,110,070 and total liabilities of $1,209,664 exceeding total assets of $99,594.

  • · Operating expenses surged to $632,583 in Q1 2026 from $100,000 in Q1 2025, driven by $390,104 in professional fees and $190,932 in advertisement and marketing expenses.
  • · Cash provided by financing activities was $513,000 from prepaid warrants, while cash used in operating activities was $415,931.
  • · Notes payable to related parties increased to $491,186 from $473,523, with the largest being the CMB Communications June 2023 Note at $157,026.
  • · Litigation liability rose slightly to $682,381 from $671,377.
  • · The company has a net operating loss carryforward of $20,825,433, fully offset by a valuation allowance, resulting in no deferred tax asset.
  • · Common stock issuable of $240,000 was recorded at March 31, 2026, compared to $0 at December 31, 2025.
  • · Additional paid-in capital decreased sharply to $5,284,199 from $16,216,112, reflecting stock-based compensation and warrant issuances.
Camlin Fine Sciences Limited Regulatory Action neutral materiality 2/10

20-05-2026

Camlin Fine Sciences Limited has announced a conference call for investors and analysts on May 26, 2026, to discuss its audited financial results for the quarter and year ended March 31, 2026. The call will be led by senior management including the Chairman & Managing Director, Managing Director, and CFO. The filing contains no financial data or performance metrics.

  • · The conference call is scheduled for Tuesday, May 26, 2026 at 5:00 PM IST.
  • · Pre-registration is required via a provided link.
  • · Dial-in numbers are provided for India, USA, UK, Singapore, and Hong Kong.
  • · The company states that no unpublished price-sensitive information (UPSI) will be discussed.
  • · The date of the call is subject to change due to exigencies.
Camlin Fine Sciences Limited Regulatory Action neutral materiality 5/10

20-05-2026

Camlin Fine Sciences Limited has informed the stock exchanges that its Board of Directors will meet on May 26, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's equity shares remains closed from April 1, 2026, until 48 hours after the financial results are made public.

  • · Board meeting scheduled for Tuesday, May 26, 2026
  • · Agenda includes approval of audited standalone and consolidated financial results for Q4 FY26 and full year FY26
  • · Trading window has been closed since April 1, 2026, and will reopen 48 hours after the results are made public
  • · Filing made under Regulation 29 of SEBI (LODR) Regulations, 2015
Strides Pharma Science Limited Insolvency neutral materiality 5/10

20-05-2026

Strides Pharma Science Limited announced that the Hon'ble NCLT, Bengaluru Bench has approved the Scheme of Arrangement for Demerger of the Demerged Undertaking (Life Sciences business and Digital Innovation business) of Arco Lab Private Limited (wholly owned subsidiary) into Pivot Path Private Limited (wholly owned subsidiary of Arco Lab). The certified order is awaited; upon filing with the Registrar of Companies the Scheme will become effective, with an Appointed Date of April 10, 2025.

  • · NCLT approval order was pronounced on May 18, 2026 and made available on the NCLT portal on May 20, 2026.
  • · Appointed Date for demerger is April 10, 2025 (retrospective).
  • · Upon effectiveness: Pivot Path becomes a wholly owned subsidiary of Strides; Arco Lab's shares in Pivot Path will be extinguished; Strides will receive equity shares in Pivot Path per the share entitlement ratio (not specified).
  • · Arco Lab and Pivot Path are applying for a certified copy of the NCLT order to file with the Registrar of Companies.
Sarla Performance Fibers Limited Buyback mixed materiality 8/10

20-05-2026

Sarla Performance Fibers Limited announced its standalone and consolidated financial results for the quarter and year ended March 31, 2026. Standalone revenue from operations for the quarter was ₹277.16 lakh, down from ₹373.81 lakh in the previous quarter and ₹336.63 lakh in the same quarter last year, while the full-year revenue increased to ₹1,226.40 lakh from ₹1,062.26 lakh. However, the company reported a standalone loss after tax of ₹15.16 lakh for the quarter, compared to a profit of ₹68.89 lakh in the prior quarter and ₹57.96 lakh in the year-ago quarter, and a full-year profit of only ₹11.16 lakh versus a loss of ₹96.03 lakh in the prior year.

  • · The standalone results show a sharp sequential and year-on-year decline in revenue and a swing to loss in Q4 FY26, while the full year still managed a modest profit of ₹11.16 lakh compared to a loss of ₹96.03 lakh in FY25.
  • · Consolidated total income from operations grew 7.7% QoQ and 5.5% YoY in Q4 FY26, and 11.0% for the full year, indicating better performance at the group level.
  • · Consolidated operating profit (PBIDT) improved 18.9% QoQ and 37.9% YoY in Q4 FY26, and 25.0% for the full year.
  • · No exceptional items were reported for any period.
  • · The company's paid-up equity share capital remained unchanged at ₹3,222.74 lakh (face value ₹10 per share).
Vikas WSP Ltd. Insolvency neutral materiality 5/10

20-05-2026

Vikas WSP Ltd., currently under Corporate Insolvency Resolution Process (CIRP), informed the exchange that its matters before the NCLT Chandigarh Bench on 18th May 2026 could not be taken up due to bench unavailability. The matters, including approval of the Resolution Plan and a Section 19(2) application, are now listed for hearing on 2nd June 2026. This update indicates a procedural delay with no material financial impact disclosed.

  • · The company has been under CIRP since 2nd February 2022.
  • · The Resolution Plan approval application is IA (I.B.C.) No. 1538/2022.
  • · The Section 19(2) cooperation application is IA (I.B.C.) No. 764/2022.
  • · The matters were originally scheduled for 18th May 2026 but adjourned due to bench unavailability.
  • · Next hearing date is 2nd June 2026 before the regular bench.
NGL Fine-Chem Limited Regulatory Action neutral materiality 4/10

20-05-2026

NGL Fine-Chem Limited has informed the stock exchanges that its Board of Directors, scheduled to meet on May 21, 2026, will consider and recommend a final dividend for FY2025-26, in addition to approving audited financial results and fixing AGM-related dates. The trading window remains closed until May 23, 2026, per insider trading regulations.

  • · Board meeting scheduled for May 21, 2026, to consider audited consolidated and standalone financial results for Q4 and FY ended March 31, 2026.
  • · Board will also fix the date of the Annual General Meeting (AGM), book closure, and record date for AGM and e-voting.
  • · Trading window closed from April 1, 2026, and will remain closed until 48 hours after the results declaration (May 23, 2026).
Tricom Fruit Products Ltd Insolvency neutral materiality 3/10

20-05-2026

Tricom Fruit Products Ltd informed BSE that the 16th meeting of the Committee of Creditors (CoC) will be held on May 26, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window for directors, officers, and designated employees has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of the unaudited financial results. No financial figures were provided in this filing.

  • · The Company is under insolvency proceedings as evidenced by the Committee of Creditors meeting.
  • · Trading window closed from April 1, 2026, until 48 hours after the declaration of financial results.
  • · Filing made under Regulation 30 of SEBI (LODR) Regulations, 2015.
Gennex Laboratories Ltd Regulatory Action neutral materiality 3/10

20-05-2026

Gennex Laboratories Ltd has submitted newspaper publications to stock exchanges regarding a Board Meeting scheduled for May 30, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The notices were published in Business Standard (English) and Saksham (Telugu local) on May 20, 2026. No financial results or performance data are included in this filing.

  • · Board meeting scheduled for Saturday, May 30, 2026 at the corporate office in Hyderabad.
  • · Meeting agenda includes adoption of audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, along with statutory auditors' reports.
  • · Newspaper notices published in Business Standard (English) and Saksham (Telugu local) on May 20, 2026.
  • · The notice is also available on the company's website and BSE website.
Jay Bharat Maruti Limited IPO Listing neutral materiality 3/10

20-05-2026

Jay Bharat Maruti Limited has initiated the voluntary delisting of its equity shares from the Calcutta Stock Exchange (CSE), as approved by the board on May 19, 2026. The company emphasized that there has been no trading activity on the CSE for several years, making continued listing costly and without meaningful benefit to shareholders. Shares will continue to be listed and traded on NSE and BSE, which offer nationwide liquidity. This move is intended to reduce avoidable compliance and listing costs.

  • · Board approved delisting from CSE on May 19, 2026, and a public notice was published in Business Standard (English, Hindi), and Duranta Barta (Bengali) on May 20, 2026
  • · The delisting re-application is in continuation of the company's earlier application to delist from CSE in 2003, which was approved by members in the 16th AGM held on August 21, 2003
  • · There has been no trading activity in the company's equity shares on CSE for several years
FutureCorp Space Acquisition 1 S-1 mixed materiality 8/10

20-05-2026

FutureCorp Space Acquisition 1 filed an S-1 registration statement on May 19, 2026, for an initial public offering of 20,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half of one redeemable warrant, aiming to raise $200,000,000. The blank check company has not yet selected a business combination target and has not initiated substantive discussions with any target. The offering includes a 45-day over-allotment option for up to 3,000,000 additional units, and the sponsor and underwriter have committed to purchase 6,000,000 private placement warrants at $1.00 per warrant, generating $6,000,000. However, the sponsor acquired 5,750,000 founder shares at a nominal price of $0.004 per share, resulting in immediate and substantial dilution for public shareholders, and the company has no identified target, introducing significant uncertainty.

  • · The company is a blank check company incorporated in the Cayman Islands and has not selected any business combination target.
  • · The warrants become exercisable 30 days after the initial business combination and expire five years after that combination.
  • · Public shareholders have redemption rights at a per-share price equal to the trust account balance (less taxes) divided by outstanding public shares, but shareholders holding more than 15% of shares sold in the offering are restricted from redeeming more than 15% without prior consent.
  • · Non-managing sponsor investors may purchase private placement warrants at $1.00 per warrant and receive founder shares at $0.004 per share, potentially realizing enhanced returns.
  • · The underwriters receive upfront discounts and deferred underwriting commissions on units purchased by non-managing sponsor investors, if any.
  • · The company will not use trust account proceeds to pay excise taxes under the Inflation Reduction Act of 2022.
  • · The offering is subject to completion and the registration statement is not yet effective.
Finelistings Technologies Limited Regulatory Action neutral materiality 3/10

20-05-2026

Finelistings Technologies Limited has informed BSE that a Board Meeting will be held on May 28, 2026, to consider and approve the audited financial results for the half year and year ended March 31, 2026. The meeting will take place at the company's registered office in New Delhi. No financial figures or performance comparisons are provided in this filing.

  • · Board Meeting scheduled for Thursday, 28th May 2026 at 4:00 PM IST.
  • · Meeting location: Office 507, 5th Floor, Eros Corporate Tower, Nehru Place, South Delhi, New Delhi, India, 110019.
  • · Agenda includes approval of Audited Financial Results for Half Year and Year ended 31st March 2026 along with Auditor's Report.
  • · Company CIN: L74999DL2018PLC331504; Security ID: FTL / Code: 544173.
DEEP FISSION, INC. S-1 neutral materiality 8/10

20-05-2026

Deep Fission, Inc. filed an S-1 registration statement on May 20, 2026, for an IPO of 6,000,000 shares of common stock at an anticipated price range of $24.00 to $26.00 per share. The company has applied to list on Nasdaq under the symbol 'FISN'.

  • · The filing date is May 20, 2026.
  • · The anticipated public offering price range is $24.00 to $26.00 per share.
  • · The company is a Delaware corporation with principal executive offices in Berkeley, California.
  • · The common stock has no established public trading market.
Morgan Stanley Ethereum Trust S-1/A neutral materiality 7/10

20-05-2026

Morgan Stanley Ethereum Trust filed Amendment No.1 to its S-1 registration statement on May 20, 2026, for an IPO of shares to be listed on NYSE Arca. The trust aims to track ether's price and staking rewards, with staking activities commencing at offering. The filing includes details on custodians (BNY and Coinbase Custody), staking services providers, and creation/redemption mechanisms. No financial figures are provided in this preliminary prospectus.

  • · The trust is structured as a grantor trust for U.S. federal income tax purposes.
  • · Staking rewards will be distributed monthly (at least quarterly) to shareholders.
  • · Authorized Participants can create/redeem shares in cash or in-kind.
  • · The trust will not use leverage, derivatives, or similar arrangements.
  • · The Delegated Sponsor may allocate ether between custodians (BNY and Coinbase Custody) at its discretion.
SOCIETY PASS INCORPORATED. 8-K negative materiality 9/10

20-05-2026

Society Pass Incorporated (SOPA) received a delisting notice from Nasdaq on May 14, 2026, following its Chapter 11 bankruptcy filing on May 12, 2026. Trading of the common stock will be suspended at the opening of business on May 21, 2026, and a Form 25-NSE will be filed to remove the stock from listing and registration. The company intends to appeal the delisting determination, but faces significant uncertainty regarding its listing status and bankruptcy proceedings.

  • · The delisting determination was based on Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 due to the Chapter 11 filing.
  • · The company filed for Chapter 11 bankruptcy on May 12, 2026 (the Petition Date).
  • · The company intends to appeal the delisting determination, but no guarantee of success is provided.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
ENTRAVISION COMMUNICATIONS CORP 8-K neutral materiality 5/10

20-05-2026

Entravision Communications Corp. mutually terminated its Cooperation Agreement with Alexandra Seros and related trusts on May 18, 2026. The agreement had been in place since May 4, 2023, and governed board nomination rights and stock ownership commitments. As a result, all rights and obligations under the agreement have been terminated, but Thomas Strickler (originally nominated under the agreement) will remain on the board. No financial figures are disclosed in this filing.

  • · The Cooperation Agreement was originally dated May 4, 2023.
  • · The termination is mutual between the Company and the Stockholders.
  • · Thomas Strickler will remain on the board despite the termination of the agreement.
Sachem Capital Corp. 10-Q negative materiality 8/10

20-05-2026

Sachem Capital Corp. reported a net loss of $6.1M for Q1 2026, a sharp reversal from net income of $0.9M in Q1 2025, driven by a $5.4M provision for credit losses (vs. $1.1M a year ago) and $1.6M in transaction expenses. Net interest income declined 4.9% to $3.6M, while total assets grew 2.9% to $473.3M. The net loss attributable to common shareholders was $7.2M, or $(0.15) per share, compared to a loss of $0.2M in the prior-year period.

  • · Interest income from loans increased 11.0% YoY to $8.8M, but interest income from LLC investments fell 55.8% to $0.9M.
  • · Total operating expenses rose 73.1% to $5.7M, driven by a $1.6M transaction expense and higher compensation costs.
  • · Net cash provided by operating activities improved to $0.8M from $0.2M in Q1 2025.
  • · Investing activities used $16.5M in cash, compared to providing $5.7M a year ago, primarily due to lower loan principal collections.
  • · Financing activities provided $16.3M, largely from $10.0M in new senior secured notes and net line of credit borrowings.
  • · Loans held for investment, net, decreased 6.2% to $341.2M from $363.7M at year-end 2025.
  • · Investments in developmental real estate surged to $46.0M from $9.7M at December 31, 2025, reflecting a $35.9M restructuring of a loan held for investment.
  • · The allowance for credit losses on loans increased to $12.4M from $11.5M at year-end 2025.
  • · Dividends paid on common shares totaled $2.4M, up slightly from $2.4M in Q1 2025.
Starfighters Space, Inc. 10-Q negative materiality 8/10

20-05-2026

Starfighters Space, Inc. reported a net loss of $4.27M for Q1 2026, widening from a $2.65M loss in Q1 2025, driven by a 116% surge in operating expenses to $4.05M. Cash and restricted cash fell to $2.14M from $4.63M at year-end 2025, while total assets declined to $26.34M from $28.39M. However, the company raised no new equity in the quarter and recorded a $1.53M due from shareholder and a $395k loss from misappropriation of assets.

  • · Stock-based compensation of $1.80M was the largest non-cash expense in Q1 2026, up from $0 in Q1 2025.
  • · Professional fees surged to $1.33M in Q1 2026 from $192k in Q1 2025.
  • · Consulting fees increased to $1.12M from $390k year-over-year.
  • · Advertising and promotion expenses rose to $508k from $81k.
  • · The company recorded a $395k loss from misappropriation of assets in Q1 2026.
  • · A $1.53M due from shareholder was recorded as of March 31, 2026, with a corresponding related party notes payable of the same amount.
  • · Short-term investments decreased to $13.21M from $15.27M at year-end 2025.
  • · Restricted cash increased to $736k from $51k at December 31, 2025.
  • · Grant payable increased to $744k from $355k at year-end 2025.
  • · Net cash used in operating activities was $3.96M in Q1 2026 vs $1.67M in Q1 2025.
  • · No proceeds from private placements or financing activities in Q1 2026, compared to $4.10M in Q1 2025.
  • · All convertible notes (Tranches 1-5) were fully converted by December 31, 2025, with no remaining balance.
  • · Net loss per share improved to $(0.10) from $(0.13) due to a higher share count.
JAGSONPAL SERVICES LIMITED Default neutral materiality 2/10

20-05-2026

Jagsonpal Services Limited has informed the stock exchange that a Board Meeting will be held on 30th May 2026 to consider and approve the audited financial results for the fourth quarter and year ended 31st March 2026. The trading window for designated persons will remain closed until 1st June 2026.

  • · The company was formerly known as Jagsonpal Finance and Leasing Limited
  • · Trading window closes until 1st June 2026 following the board meeting
  • · Registered office: 2, B Wing, 4th Floor, Connekt, Silver Utopia, Chakala, Andheri East, Airport, Mumbai-400099
Laird Superfood, Inc. 8-K neutral materiality 4/10

20-05-2026

On May 18, 2026, Mr. Doug Behrens resigned from the Board of Directors and the Compensation Committee of Laird Superfood, Inc., effective immediately, for personal reasons. The company clarified that his resignation was not due to any disagreement with the company's operations, policies, or practices. This departure reduces the board's size and removes a member from the compensation committee, but no successor has been announced.

  • · The resignation was effective immediately on May 18, 2026.
  • · The Form 8-K was filed on May 20, 2026, and signed on May 19, 2026.
  • · No replacement director or committee member has been named.
  • · Mr. Behrens had been a member of the Compensation Committee.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Global High-Priority Regulatory Events

🇺🇸 More from United States

View all →